Vetma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,090,959 | 1,253,024 | 1,609,167 | 1,962,026 | 2,320,690 | 2,521,719 | 2,758,334 | 2,944,750 |
| Profit before tax | 103,598 | 96,984 | 162,006 | 181,346 | 153,840 | 283,217 | 331,157 | 422,336 |
| Net profit | 85,518 | 81,561 | 138,688 | 150,778 | 129,478 | 237,310 | 279,806 | 347,283 |
| Equity | 354,296 | 435,857 | 574,545 | 705,323 | 811,800 | 1,049,111 | 1,292,917 | 1,609,200 |
| Liabilities | 183,684 | 168,762 | 189,793 | 133,442 | 196,803 | 199,640 | 293,167 | 230,684 |
| Non-current assets | 17,889 | 60,568 | 63,113 | 52,571 | 35,499 | 39,051 | 45,108 | 38,170 |
| Current assets | 520,091 | 544,051 | 701,225 | 786,194 | 973,104 | 1,209,700 | 1,540,976 | 1,801,714 |
| Total assets | 537,980 | 604,619 | 764,338 | 838,765 | 1,008,603 | 1,248,751 | 1,586,084 | 1,839,884 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 480,565 | 554,343 | 570,452 |
| Social insurance contributions | - | - | - | - | - | 79,171 | 90,374 | 86,972 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +20.8% | +14.9% | +28.4% | +21.9% | +18.3% | +8.7% | +9.4% | +6.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 15.9% | 13.5% | 18.1% | 18.0% | 12.8% | 19.0% | 17.6% | 18.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 24.1% | 18.7% | 24.1% | 21.4% | 15.9% | 22.6% | 21.6% | 21.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.8% | 6.5% | 8.6% | 7.7% | 5.6% | 9.4% | 10.1% | 11.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.5% | 7.7% | 10.1% | 9.2% | 6.6% | 11.2% | 12.0% | 14.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 127,103 | 153,431 | 163,645 | 222,117 | 194,743 | 196,498 | 205,590 | 232,480 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vetma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-01-27 | 2022-02-02 | 4.56 |
| 2021-12-16 | 2021-12-19 | 5063.92 |
Vetma - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vetma, UAB (code 300557995) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €2.94M, up 6.8% year on year and 16.8% over two years. Net profit reached €347.3K, compared with €279.8K in 2024 and €237.3K in 2023, showing a steady upward earnings trend. Profit margin improved from 9.4% in 2023 to 10.1% in 2024 and 11.8% in 2025. The balance sheet also expanded: total assets increased to €1.84M in 2025 from €1.59M in 2024 and €1.25M in 2023. Equity rose to €1.61M, while liabilities remained moderate at €230.7K, supporting a strong equity position. Key ratios for 2025 were also solid, with ROE at 21.6%, ROA at 18.9%, debt-to-equity at 0.14, and asset turnover at 1.60x. Revenue per employee stood at €245.4K, indicating relatively high productivity.